Press Releases

 
Select:
Jan 05, 2021
Elite Pharmaceuticals, Inc. Appoints Dr. Jason M. LePree as Vice President of Scientific Affairs

Nov 24, 2020
Elite Pharmaceuticals, Inc. Issues Statement on Product Approval Listing

Nov 16, 2020
Elite Pharmaceuticals, Inc. Reports Financial Results For The Second Quarter of Fiscal Year 2021 Ended September 30, 2020 and Provides Conference Call Information

Nov 11, 2020
Elite Pharmaceuticals, Inc. To Host Conference Call To Provide Corporate Update and Discuss Second Quarter of Fiscal Year 2021 Results on November 17, 2020

Aug 14, 2020
Elite Pharmaceuticals, Inc. Reports Financial Results For The First Quarter Of Fiscal Year 2021 Ended June 30, 2020 And Provides Conference Call Information

Aug 12, 2020
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter of Fiscal Year 2021 Results on August 17, 2020

Jun 29, 2020
Elite Pharmaceuticals, Inc. Reports Financial Results for The Fiscal Year Ended March 31, 2020 and Provides Conference Call Information

Jun 24, 2020
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Year-End Financial Results on June 30, 2020

Mar 31, 2020
Elite Pharmaceuticals Announces Commercial Launch of Generic Adderall XR(R) with Marketing Partner Lannett Company

Feb 10, 2020
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2020 Ended December 31, 2019 and Provides Conference Call Information

   1    2   3   4   5   6